Literature DB >> 9417913

Structural organization of the human flavin-containing monooxygenase 3 gene (FMO3), the favored candidate for fish-odor syndrome, determined directly from genomic DNA.

C T Dolphin1, J H Riley, R L Smith, E A Shephard, I R Phillips.   

Abstract

The inherited metabolic disorder trimethylaminuria (fish-odor syndrome) is associated with defective hepatic N-oxidation of dietary-derived trimethylamine catalyzed by flavin-containing monooxygenase (FMO). As FMO3 encodes the major form of FMO expressed in adult human liver, it represents the best candidate gene for the disorder. The structural organization of FMO3 was determined by sequencing the products of exon-to-exon and vectorette PCR, the latter through the use of vectorette libraries constructed directly from genomic DNA. The gene contains one noncoding and eight coding exons. Knowledge of the exon/intron organization of the human FMO3 gene enabled each of the coding exons of the gene, together with their associated flanking intron sequences, to be amplified from genomic DNA and will thus facilitate the identification of mutations in FMO3 in families affected with fish-odor syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9417913     DOI: 10.1006/geno.1997.5031

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  9 in total

1.  Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population.

Authors:  Makiko Shimizu; Charles K Allerston; Elizabeth A Shephard; Hiroshi Yamazaki; Ian R Phillips
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

2.  Molecular cloning, sequence characterization, SNP detection, and tissue expression analysis of duck FMO3 gene.

Authors:  Peng Wang; Jiangxia Zheng; Lujiang Qu; Ling Lian; Guiyun Xu; Ning Yang
Journal:  Mol Cell Biochem       Date:  2013-04-28       Impact factor: 3.396

3.  Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity.

Authors:  E Störmer; I Roots; J Brockmöller
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

4.  Trimethylaminuria: causes and diagnosis of a socially distressing condition.

Authors:  Richard J Mackay; Christopher J McEntyre; Caroline Henderson; Michael Lever; Peter M George
Journal:  Clin Biochem Rev       Date:  2011-02

Review 5.  Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectives.

Authors:  Irfan M Hisamuddin; Vincent W Yang
Journal:  Pharmacogenomics       Date:  2007-06       Impact factor: 2.533

6.  Clinical utility gene card for: Trimethylaminuria - update 2014.

Authors:  Elizabeth A Shephard; Eileen P Treacy; Ian R Phillips
Journal:  Eur J Hum Genet       Date:  2014-10-22       Impact factor: 4.246

7.  Simultaneous Measurement of Urinary Trimethylamine (TMA) and Trimethylamine N-Oxide (TMAO) by Liquid Chromatography-Mass Spectrometry.

Authors:  Xun Jia; Lucas J Osborn; Zeneng Wang
Journal:  Molecules       Date:  2020-04-17       Impact factor: 4.411

Review 8.  TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review.

Authors:  Ye Zixin; Chen Lulu; Zeng Xiangchang; Fang Qing; Zheng Binjie; Luo Chunyang; Rao Tai; Ouyang Dongsheng
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

Review 9.  Gut microbiota derived metabolites in cardiovascular health and disease.

Authors:  Zeneng Wang; Yongzhong Zhao
Journal:  Protein Cell       Date:  2018-05-03       Impact factor: 14.870

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.